Status:
COMPLETED
Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Danish Breast Cancer Cooperative Group
Danish Cancer Society
Conditions:
Breast Cancer
Persistent Pain
Eligibility:
FEMALE
18+ years
Brief Summary
The study is a prospective cohort study following breast cancer patients from before surgery to one year after. The aims of the study are to determine risk factors that predispose to the development o...
Detailed Description
The aim of the study is 1) to determine pre-, intra and post surgical risk factors for persistent pain after breast cancer treatment 2) to examine the prevalence of persistent pain 6 and 12 months aft...
Eligibility Criteria
Inclusion
- Diagnosed with breast cancer
- 18 years or older
Exclusion
- unable to give written consent
- unable to understand Danish
- Previous cosmetic surgery in the breast
- Previous surgery in ipsilateral breast
- Bilateral cancer
- Concomitant corrective surgery on contralateral side
- Pregnant
- Other disease or injury in the nervous system
- Psychiatric disease
- Alcohol or drug abuse
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
545 Patients enrolled
Trial Details
Trial ID
NCT01523132
Start Date
November 1 2011
End Date
November 1 2014
Last Update
April 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Copenhagen University Hospital
Copenhagen, Denmark, DK-2100